Boston Scientific
"Advancing Science for Life"
Global US medical device manufacturer focused on minimally invasive therapies for cardiovascular, neurological, digestive, urological, and pelvic conditions.
Boston Scientific Corporation, founded on June 29, 1979 by John E. Abele and Pete Nicholas, is headquartered in Marlborough, Massachusetts. The company is a leading global manufacturer of medical devices with a focus on minimally invasive treatments for cardiovascular, respiratory, neurological, digestive, urological, and pelvic conditions.
Boston Scientific operates through three segments: Rhythm and Neuro, Cardiovascular, and MedSurg. With over 30,000 employees worldwide and annual revenue exceeding $16.7 billion in 2024, the company has completed more than 40 acquisitions under CEO Michael Mahoney. Boston Scientific also invests in virtual reality and robotic-assisted surgical technologies to advance procedural precision and patient outcomes.
Primary type & automation activities this supplier delivers:
Endoscopy Systems
Minimally invasive endoscopic devices for gastrointestinal and pulmonary diagnosis and treatment under the MedSurg segment.
Contact Boston Scientific
WEBSITE
https://www.bostonscientific.comPHONE
18882721001HEADQUARTERS
United States
Company Facts
Founded
1979
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
AI Ultrasound Robots Revolutionize Congenital Heart Defect Surgery with Intelligent Imaging
Recently, a medical team in China successfully performed a congenital heart defect closure surgery using an AI-assisted ultrasound robot. This operation, conducted by the Sixth Medical Center of the PLA General Hospital, involved a 48-year-old male patient and marks the first global use of an AI ultrasound robot with intelligent imaging capabilities for such minimally invasive treatment. This breakthrough signifies a shift in medical robotics from traditional execution tools to intelligent assistance systems. Previously, interventional surgical robots primarily handled mechanical tasks, while physicians relied on their experience to interpret ultrasound images. The AI ultrasound robot enhances this process by integrating image recognition, real-time analysis, and operational guidance, enabling automatic image acquisition and abnormal structure identification, which is crucial for precise placement of occluders in complex cardiac structures. As the field of medical robotics rapidly evolves, the cardiovascular sector is a key area for AI exploration due to the high precision and risk involved in heart interventions. The successful application of AI ultrasound robots in China reflects a significant trend towards redistributing medical resources, potentially improving access to high-quality healthcare in underserved regions. No further timeline was disclosed at the time of publication.
AI in Healthcare Surgical Robotics Cardiovascular Technology Medical Imaging Precision Medicine
China Achieves First AI-Guided Surgery for Congenital Heart Disease Using Intelligent Robotics
Recently, a medical team in China completed the world's first AI ultrasound robot-assisted interventional procedure for congenital heart disease. Conducted by the Cardiovascular Medicine Department of the Sixth Medical Center of the PLA General Hospital, this surgery marks a significant milestone in the clinical application of intelligent technology in healthcare. This breakthrough is crucial as it signifies the integration of artificial intelligence into one of the most critical aspects of surgical procedures: interpreting images, assessing positions, and aiding doctors in formulating operational plans. Traditionally, cardiovascular interventions heavily relied on physician experience, particularly in complex cases where accurate understanding of heart structure changes is essential. Looking ahead, the focus may shift from merely achieving higher precision with robotic arms to whether robots can comprehend medical images, analyze patient conditions, and adapt strategies in real-time. The integration of AI models, medical imaging, and robotic control systems will be vital for advancing surgical capabilities, especially in areas lacking experienced specialists.
AI in Healthcare Surgical Robotics Medical Imaging Cardiovascular Surgery
China Achieves World-First with AI-Driven Ultrasound Robot for Heart Surgery
A groundbreaking achievement in cardiology occurred when a Chinese medical team successfully utilized an AI-driven, ultrasound-guided robot to perform a transcatheter closure for congenital heart disease in a 48-year-old patient. This milestone was reached at the Sixth Medical Center of the Chinese PLA General Hospital, also known as 301 Hospital, marking a significant advancement in surgical techniques. The importance of this development lies in its potential to enhance surgical precision and transform cardiovascular care. Unlike existing surgical robots that require direct human control, this innovative system employs deep learning algorithms to autonomously navigate and perform the procedure, significantly reducing radiation exposure for both patients and medical staff. Looking ahead, the implications of this technology are profound, as it could facilitate the expansion of specialized healthcare access globally. The intelligent automation of complex ultrasound-guided procedures may streamline workflows, reduce human error, and ultimately improve patient outcomes in cardiovascular interventions. No further timeline was disclosed at the time of publication.
Science
Why Pittsburgh Compressed 12 Events Into One Week | StartUP PGH 2026
Pittsburgh companies raised $2.29 billion last year, but the region's own investors have just $23.2 million left to deploy, less than one average deal. StartUP PGH 2026, opening September 14 with 250-plus robotics exhibitors and 65-plus pitching startups, is built to bring outside investors to town.
Enovis to Acquire eCential Robotics for Over $180 Million to Enhance Surgical Technology
Enovis Corp. has announced a binding offer to acquire eCential Robotics for approximately €155 million, exceeding $180 million. This acquisition aims to integrate eCential's modular surgical robotics platform into Enovis' ASTRA technology platform, enhancing its capabilities in orthopedic surgery. The addition of eCential's robotic technology is significant as it aligns with Enovis' strategy to provide surgeons with diverse technological options. CEO Damien McDonald emphasized that this move will strengthen their market position and expand strategic opportunities in robotic-assisted surgery, addressing evolving market demands. Looking ahead, Enovis plans to finalize the acquisition by the end of 2026, with an initial payment of €176 million and potential additional payments based on performance milestones. The integration of eCential's expertise is expected to accelerate the development of next-generation robotic solutions, particularly in knee and shoulder surgeries, within the next two years.
Financial Healthcare Robotics Markets / Industries Mergers & Acquisitions News Robots / Platforms
China Establishes Reimbursement Group for Robot-Assisted Surgery in DRG/DIP 3.0 Plan
China's National Healthcare Security Administration has officially created a distinct reimbursement group for robot-assisted surgery within the DRG/DIP 3.0 plan. This significant move addresses a pricing gap that could have adversely affected hospitals that choose to adopt surgical robots. The establishment of this reimbursement group is crucial as it encourages the integration of advanced robotic technologies in surgical procedures. By providing a clear reimbursement framework, hospitals may be more inclined to invest in surgical robots, ultimately enhancing patient care and operational efficiency. Looking ahead, stakeholders in the healthcare sector should monitor the impact of this new reimbursement structure on the adoption rates of robotic surgical systems. No further timeline was disclosed at the time of publication.
Enovis Acquires eCential Robotics for €155 Million to Enhance Surgical Orthopedic Robots
Enovis announced its acquisition of eCential Robotics for €155 million (approximately $180 million) to advance the development of surgical robots for orthopedic procedures. This strategic move aims to close a competitive gap and formalize an existing collaboration with eCential, which previously developed Johnson & Johnson's Velys Spine surgical robot. Enovis plans to launch a knee robot in late 2028 and a shoulder robot in 2029, enhancing its Astra enabling technology system with robotics capabilities. The acquisition is significant as it positions Enovis to compete more effectively in the orthopedic surgical robot market, where rivals like Johnson & Johnson and Stryker are already active. Enovis CEO Damien McDonald emphasized that integrating robotics technology is crucial for the company's long-term growth strategy. The planned knee and shoulder robots are expected to feature unique capabilities, including a robotic arm with seven degrees of freedom, setting them apart from existing offerings in the market. Looking ahead, Enovis aims to leverage eCential's expertise to accelerate product development and respond more effectively to clinician needs. The acquisition includes an upfront payment and potential milestone payments totaling up to €35 million, contingent on the successful development of the new devices. No further timeline was disclosed at the time of publication.
McKesson Faces Major Data Breach as Hackers Claim Millions of Patient Records Stolen
A hacking group known as ShinyHunters has claimed responsibility for a recent cyberattack on McKesson, a leading U.S. pharmaceutical distributor. The breach involved unauthorized access to several cloud-hosted accounts, resulting in the theft of sensitive patient data, including personal information and protected health information related to oncology and medical-surgical units. This incident highlights the increasing vulnerability of healthcare companies to cyberattacks, as hackers target organizations to steal sensitive medical data for extortion purposes. McKesson, which handles a significant amount of patient data across the United States, confirmed the breach and reported potential service degradation due to the attack. The hackers demanded a ransom of $55 million to prevent the public release of the stolen data. As cyberattacks on healthcare organizations become more frequent, industry stakeholders should remain vigilant. The recent breaches affecting companies like Boston Scientific and Stryker indicate a troubling trend in the sector. No further timeline was disclosed at the time of publication.
Security cyberattack cybersecurity data breach healthcare
Five Innovative Robots Transforming Modern Medicine and Patient Care
The integration of robots in healthcare has evolved from a futuristic concept to a reality, with machines now playing vital roles in operating rooms and rehabilitation centers worldwide. These robots enhance surgical precision, disinfect hospital environments, and assist in patient recovery, showcasing their diverse applications in modern medicine. The da Vinci Surgical System, developed by Intuitive Surgical, stands out as the most widely adopted surgical robot globally, approved by the FDA since 2000. It enables surgeons to perform complex procedures with enhanced dexterity and reduced tremors, impacting various specialties such as urology and gynecology. Meanwhile, the Xenex LightStrike robot addresses the critical issue of hospital-acquired infections by using ultraviolet light to disinfect rooms quickly and effectively, contributing to patient safety and infection control. As the healthcare landscape continues to embrace robotic technology, stakeholders should monitor advancements in robotic applications and their implications for patient care. The ongoing development of robots like the da Vinci and LightStrike highlights the potential for improved outcomes in surgery and infection management. No further timeline was disclosed at the time of publication.
Lists
Noah Medical Plans Hong Kong IPO to Support Expansion in Mainland China
Noah Medical, a surgical robotics firm backed by SoftBank, is preparing to file for a Hong Kong listing as early as next year. The company aims to raise over $100 million to bolster its expansion efforts in mainland China. Founder Zhang Jian emphasized that Hong Kong's status as an international financial center makes it an ideal location for their listing. The move is significant as Noah Medical seeks to tap into the growing demand for surgical robotics in China. With regulatory approval from China's drug regulator obtained in November, the company is targeting hospitals such as Sir Run Run Shaw Hospital for its products. Currently, 90% of Noah Medical's revenue comes from the U.S., where its surgical robots have successfully treated around 15,000 patients. Looking ahead, the company’s listing could provide the necessary capital to enhance its market presence in China. No further timeline was disclosed at the time of publication.
Surgical Robots Shine at International Medical Expo: Domestic Innovations Reshape Operating Rooms
From August 14 to 16, the 32nd China International Medical Instrument and Equipment Exhibition took place at the National Convention Center. Surgical robots became the highlight of the event, which focused on showcasing innovative medical devices and digital healthcare technologies. Attendees observed demonstrations of various surgical robots, including both international models like the da Vinci and domestic innovations, highlighting their evolution from auxiliary tools to primary surgical instruments. The significance of this event lies in the emergence of domestic surgical robot companies, whose products span laparoscopic, orthopedic, and neurosurgical applications. Some of these robots have already completed thousands of surgeries in top-tier hospitals, and their competitive pricing compared to imported devices is expected to accelerate their adoption in grassroots healthcare facilities. The exhibition also featured China's medical equipment applications in Africa, reflecting the growing export of Chinese medical devices, with a notable increase in high-value products like surgical robots. Looking ahead, industry experts noted that as the costs of surgical robots decrease and demand from grassroots hospitals rises, the Chinese medical robot market is entering a growth phase. According to Frost & Sullivan, the market size for surgical robots in China is projected to exceed 50 billion yuan by 2030, with domestic production rates expected to surpass 50%. No further timeline was disclosed at the time of publication.
Surgical Robots Medical Devices Healthcare Technology AI in Medicine
ROBOTTODAY Weekly August 10 – 14, 2026
Your weekly robotics briefing: Unitree's IPO is swamped by retail demand, the US puts 100% tariffs on imported drones, LG and Nvidia commit to a 2027 humanoid, and Uber and Pony.ai bring 2,000 robotaxis to Europe.
Underactuated Robotics Russ Tedrake — RSF Specialist Shelf · Book S3 of 6
Legged robots fall over for control reasons, not mechanical ones. Tedrake's free MIT 6.832 notes explain why, and what a controller must do about it.
US Restrictions on Chinese Humanoid Robots: The Full Map
Every US restriction on Chinese humanoid robots — NDAA Sec. 163, GUARD Act, the 1260H list — plus the supply-chain math and a 4-tier map of decoupling.
ROBOTTODAY Weekly July 13 – 17, 2026
This week in robotics: Hyundai takes full ownership of Boston Dynamics, Xpeng targets 1,000 Iron humanoids a month, LimX Dynamics raises $200M pre-IPO, and Agility opens a Silicon Valley physical-AI hub. July 13–17, 2026.
Physical AI Landscape: From Digital Intelligence to the Embodied Physical World
A comprehensive industry analysis of Physical AI — covering Embodied AI, Field AI, Factory AI, VLM, World Model, VLA, and the VLA vs WAM architecture debate. Includes 20+ companies, 28 references, and the RobotToday Physical AI Landscape diagram. July 2026.
Piaggio Fast Forward Brings kilo® Autonomous Mobile Robot to Automate 2026
Piaggio Fast Forward showcases kilo®, an infrastructure-free collaborative AMR (300 lb payload, 360° LiDAR), at Automate 2026 booth #17054.
ROBOTTODAY Weekly June 30 – July 4, 2026
Unitree wins CSRC approval for China’s first humanoid IPO, Korea unveils ₩312T AI investment, RoboCup 2026 opens in Incheon, and Paris launches Europe’s inaugural Physical AI summit.
XELA Robotics Launches Next-Gen Tactile Sensors at Automate 2026
XELA Robotics unveiled five major uSkin® tactile sensor advances at Automate 2026 — including a force-sensitive nail fingertip, UMI AI integration, and fragile object handling. Full product report by RobotToday.com.
Unitree's IPO Review: What It Means for China's Humanoid Robot IPO Landscape
On 1 April 2026, China's Securities Association (CSAC) randomly selected Unitree Robotics for a mandatory on-site IPO inspection — just 12 days after its STAR Market application was accepted. The event has generated significant market commentary. This analysis examines the regulatory context, what the inspection actually means, the four core controversies in Unitree's prospectus, and the implications for competing humanoid robot companies pursuing public listings.
